By Mrinalika Roy and Sriparna Roy June 17 (Reuters) - U.S. supplies of progesterone are coming under strain, with patients, ...
People who rely on compounded GLP-1 drugs say they might not be able to afford brand-name versions, which are often not covered by insurance. Iuliia Burmistrova/Getty Images A ban on so-called copycat ...
Estrogen patches are in short supply as demand for menopause treatments skyrockets, and it could take at least a year for ...
Compounded medications currently represent an estimated 1% to 3% of all prescriptions written in the United States, according ...
According to internal financial records, the pharmacy dispensed nearly 3 million individual prescriptions to patients ...
Alexis Dunne always plans how to best treat her patients’ perimenopause and menopause symptoms. The Chicago-area physician wants to ensure that the hormone replacement therapy she prescribes helps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results